From: Endostatin gene variation and protein levels in breast cancer susceptibility and severity
Groups | Rare allele (A) carriage rate (%) | Odds Ratio (95% CI) | Test statistic (p value)# | |
---|---|---|---|---|
 | Cancer | Controls |  |  |
Overall | 136/846 (16.1%) | 115/707 (16.3%) | 0.99 (0.75–1.29) | ×2 = 0.001; p = 0.97 |
Positive family history* | 38/231 (16.5%) | 22/153 (14.4%) | 0.17 (0.66–2.07) | ×2 = 0.16; p = 0.69 |
Negative family history* | 98/615 (15.9%) | 93/554 (16.8%) | 0.94 (0.69–1.28) | ×2 = 0.1; p = 0.75 |
Young patients** vs. controls | 20/130 (15.4%) | 115/707 (16.3%) | 0.94 (0.56–1.57) | ×2 = 0.01; p = 0.90 |